| 发明名称 |
TUMOUR MARKER IN BRCA2 ASSOCIATED BREAST CANCER |
| 摘要 |
<p>The present invention relates to a diagnostic method for diagnosing the possible recurrence of breast cancer, wherein the presence of the monoclonal antibody CA- 125 is monitored in a BRCA2 tumour sample, whereby any presence of CA- 125 is indicative of metastazing BRCA2. The invention also relates to the use of monoclonal antibody CA-125, or monoclonal antibody oregovo monoclonal antibody in the preparation of a therapeutic composition for the treatment of breast cancer of the BRCA2 type.</p> |
| 申请公布号 |
WO2006132587(A1) |
申请公布日期 |
2006.12.14 |
| 申请号 |
WO2006SE00678 |
申请日期 |
2006.06.09 |
| 申请人 |
FORSKARPATENT I SYD AB;OLSSON, HAAKAN |
发明人 |
OLSSON, HAAKAN |
| 分类号 |
A61K39/395;G01N33/574;A61P35/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
